ETFs by Holding
ETFs That Hold Biogen (BIIB)
Every fund in our data that holds BIIB as a top-10 position, with each fund's yield, fees and assets.
Holdings as of Oct 16, 2026 · 18 funds
Our holdings data as of Oct 16, 2026 lists 18 funds that hold BIIB as a top-10 position. BIS (ProShares UltraShort Nasdaq Biotechnology) has the largest weighting at 6.0%, a single-stock or leveraged fund built around it. Among diversified funds, PBE holds the most, at 5.3%.
By dollars invested, IBB holds the most BIIB: about $264M, 2.4% of its $10.8B in assets. The largest fund on the list by assets is VCSH ($44.2B), with BIIB at 0.1%.
17 of the 18 funds pay a distribution; the highest current rate is SCHJ at 4.65%. BIIB itself does not currently pay a dividend.
Largest BIIB holders by dollars invested
Diversified funds ranked by how much BIIB they own: assets under management times the BIIB weighting. A broad index fund with a modest weighting often owns more BIIB than every concentrated fund combined, so this order differs from the weighting table below. Leveraged and single-stock funds are left out because their reported weight is swap notional or a cash sleeve, not dollars of BIIB.
| Fund | Name | BIIB held | BIIB weight | AUM |
|---|---|---|---|---|
| IBB | iShares Biotechnology ETF | $264M | 2.44% | $10.8B |
| XBI | SPDR S&P Biotech ETF | $165M | 1.60% | $10.3B |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | $102M | 3.51% | $2.9B |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | $42M | 3.93% | $1.1B |
| VCSH | Vanguard Short-Term Corporate Bond ETF | $35M | 0.08% | $44.2B |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | $22M | 5.29% | $412M |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | $21M | 1.78% | $1.2B |
| STNC | Hennessy Stance ESG ETF | $3M | 3.45% | $90M |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $2M | 2.16% | $113M |
| SCHJ | Schwab 1-5 Year Corporate Bond ETF | $872,623 | 0.10% | $873M |
Funds with the most BIIB by weighting
Every fund in the data, sorted by BIIB weight. Click any header to re-sort, or open a fund for its full analysis.
| Fund | Name | BIIB weight | Strategy | Distribution rate | Expense ratio | AUM | Distribution Safety Score™ |
|---|---|---|---|---|---|---|---|
| BIS | ProShares UltraShort Nasdaq Biotechnology | 6.02% | Inverse / leveraged | 4.60% | 0.95% | $2M | — |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | 5.29% | — | 0.08% | 0.59% | $412M | 97 |
| IBRN | iShares Neuroscience and Healthcare ETF | 4.78% | — | 0.99% | 0.47% | $6M | 50 |
| FMKT | The Free Markets ETF | 4.02% | — | 2.19% | 0.76% | $10M | 50 |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.93% | — | 0.11% | 0.60% | $1.1B | 66 |
| BMED | BlackRock Future Health ETF | 3.54% | — | 0.23% | 0.55% | $14M | 50 |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.51% | — | — | 0.55% | $2.9B | — |
| STNC | Hennessy Stance ESG ETF | 3.45% | — | 0.91% | 0.85% | $90M | 50 |
| IBB | iShares Biotechnology ETF | 2.44% | — | 0.02% | 0.44% | $10.8B | 84 |
| INVN | Alger Russell Innovation ETF | 2.20% | — | 0.24% | 0.55% | $11M | — |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 2.16% | — | 0.40% | 0.19% | $113M | 94 |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 1.78% | — | 0.76% | 0.15% | $1.2B | 88 |
| XBI | SPDR S&P Biotech ETF | 1.60% | — | 0.07% | 0.35% | $10.3B | 72 |
| TMFX | Motley Fool Next Index ETF | 1.41% | — | 0.05% | 0.50% | $36M | 50 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 1.34% | Leveraged | 0.32% | 0.95% | $88M | 52 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.40% | Leveraged | 0.05% | 0.96% | $620M | 9 |
| SCHJ | Schwab 1-5 Year Corporate Bond ETF | 0.10% | — | 4.65% | 0.03% | $873M | 97 |
| VCSH | Vanguard Short-Term Corporate Bond ETF | 0.08% | — | 4.57% | 0.03% | $44.2B | 97 |
How to read this list
- Holdings come from each fund's ten largest positions. A fund that holds BIIB at a smaller weight is not listed.
- Weights are as reported by each fund on or before Oct 16, 2026 and move with prices between reports. Distribution rates are annualized from each fund's latest payment.
- This is a list of exposure, not a recommendation. Open any fund for its full record.
Frequently asked questions
Which ETF has the most BIIB?
BIS has the largest BIIB weighting in our data as of Oct 16, 2026, at 6.0%. That is a concentrated fund. Among diversified funds the leader is PBE at 5.3%.
Which ETF holds the most BIIB in dollars?
IBB holds about $264M of BIIB: 2.4% of $10.8B in assets. A fund's weighting says how much of that fund is BIIB; the dollar figure says how much BIIB the fund owns, which is why a large index fund with a modest weighting can own more than every concentrated fund on the list.
How many ETFs hold BIIB?
18 funds hold BIIB as one of their ten largest positions in our data. Many more broad index funds hold it at smaller weights, which our top-10 holdings data does not cover.
Which ETFs that hold BIIB pay a dividend?
17 of the funds on this list pay a distribution. The highest current rates are SCHJ (4.65%), BIS (4.60%), VCSH (4.57%). Sort the table by distribution rate to see the rest.
Does BIIB pay a dividend?
No. Biogen does not currently pay a dividend, so a fund holding it earns no income from that position.